In its second major collaboration this year, Danish biotech NeuroSearch A/S inked a discovery deal with Johnson & Johnson unit Janssen Pharmaceutica NV for central nervous system disease drugs, a move that strengthens the company's balance sheet ahead of expected data from its late-stage Huntington's disease program. (BioWorld Today) Read More
